Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Tax Provisions (2016 - 2025)

Standard Biotools (LAB) has disclosed Tax Provisions for 16 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions fell 1116.95% to -$1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.7 million, a 688.89% decrease, with the full-year FY2024 number at $573000.0, up 0.53% from a year prior.
  • Tax Provisions was -$1.2 million for Q3 2025 at Standard Biotools, down from -$600000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $301000.0 in Q2 2023 to a low of -$1.7 million in Q1 2021.
  • A 5-year average of -$424263.2 and a median of -$151000.0 in 2025 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: soared 950.0% in 2024, then tumbled 1116.95% in 2025.
  • Standard Biotools' Tax Provisions stood at -$814000.0 in 2021, then soared by 108.6% to $70000.0 in 2022, then crashed by 142.86% to -$30000.0 in 2023, then skyrocketed by 950.0% to $255000.0 in 2024, then plummeted by 570.59% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Tax Provisions are -$1.2 million (Q3 2025), -$600000.0 (Q2 2025), and -$151000.0 (Q1 2025).